Gedik ME, Saatci O, Oberholtzer N, Uner M, et al. Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer Res 2024 Feb 6. doi: 10.1158/0008-5472.CAN-23-2812.
PMID: 38319231